Actively Recruiting

Age: 18Years +
All Genders
NCT06552676

riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU

Led by Azienda Usl di Bologna · Updated on 2024-08-14

300

Participants Needed

1

Research Sites

338 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life? Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons. At the two-year follow-up, the health-related quality of life will be assessed

CONDITIONS

Official Title

riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than 18 years
  • Presence of indication for tracheostomy
Not Eligible

You will not qualify if you...

  • Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Maggiore Hospital Carlo Alberto Pizzardi

Bologna, Italy, 40024

Actively Recruiting

Loading map...

Research Team

L

Lorenzo Gamberini, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here